Prostate Cancer with Bone Metastases: Addressing Chronic Pain from the Perspective of the Radiation Oncology Nurse Practitioner

被引:3
|
作者
Pituskin, Edith [1 ]
Fairchild, Alysa [2 ]
机构
[1] Univ Alberta, Fac Nursing, 3-141 Edmonton Clin Hlth Acad,11405-87 Ave NW, Edmonton, AB T6G 1C9, Canada
[2] Univ Alberta, Fac Med & Dent, Dept Radiat Oncol, Edmonton, AB, Canada
关键词
Bone metastases; Physical examination; Castrate-resistant prostate cancer; Pain relief; Symptom assessment; Palliative radiotherapy; PALLIATIVE RADIOTHERAPY TRIALS; FINANCIAL TOXICITY; PATIENT;
D O I
10.1016/j.soncn.2021.151175
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: To discuss the symptom burden experienced among patients with castrate-resistant prostate cancer and bone metastases and the role of the oncology nurse practitioner in evaluation for palliative radiotherapy. Data Sources: These include PubMed, international consensus documents, and clinician experience. Conclusion: Men with advanced prostate cancer may live for several years after diagnosis of bone metastases; however, pain and other difficult symptoms are problematic. Pain is effectively treated with palliative radiotherapy, but careful assessment and intervention of other difficult symptoms must be addressed over time. Implications for Nursing Practice: Nurse practitioners in radiation oncology should be well-versed in the disease trajectory of this patient population. Careful symptom inquiry and comprehensive physical examination is a key responsibility. Palliative radiotherapy, alongside analgesics and supportive care measures, can effectively reduce symptoms and improve quality of life in men with prostate cancer metastatic to bone. (c) 2021 Published by Elsevier Inc.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Radiation therapy utilisation in patients with bone metastases secondary to prostate cancer: A multicenter study
    Mazzei, M. M.
    Sindoni, A.
    Santacaterina, A.
    Platania, A.
    Marino, L.
    Umina, V.
    Girlando, A.
    Ricottone, N.
    D'Agostino, A.
    Marletta, F.
    Tamburo, M.
    Acquaviva, G.
    Spatola, C.
    Privitera, G.
    Frosina, P.
    Garufi, G.
    Bonanno, S.
    Rosso, A.
    Barone, V.
    Corallo, A.
    Sansotta, G.
    Delia, P.
    Donato, V.
    Lopes, S.
    Pisana, M.
    Runco, R.
    Risoleti, E.
    Arcudi, A.
    Rifatto, C.
    Arena, G.
    Potami, A.
    Messina, G.
    Parisi, S.
    Marletta, D.
    Pontoriero, A.
    Iati, G.
    Pergolizzi, S.
    EUROPEAN JOURNAL OF CANCER CARE, 2017, 26 (04)
  • [33] Management of cancer pain with analgetic adjuvant and weak opioid in prostate cancer bone metastases: A case series
    Ismy, Jufriady
    Emril, Dessy Rakhmawati
    Rizkidawati
    ANNALS OF MEDICINE AND SURGERY, 2020, 60 : 575 - 578
  • [34] Skin metastases from prostate cancer successfully treated with radiation therapy
    Marampon, Francesco
    Parisi, Martina
    Cicco, Piero Rodolfo
    Serpone, Maria
    Tomaciello, Miriam
    Musio, Daniela
    DE Felice, Francesca
    Tombolini, Vincenzo
    BJR CASE REPORTS, 2023, 9 (04):
  • [35] Bone Metastases and Health in Prostate Cancer: From Pathophysiology to Clinical Implications
    Baldessari, Cinzia
    Pipitone, Stefania
    Molinaro, Eleonora
    Cerma, Krisida
    Fanelli, Martina
    Nasso, Cecilia
    Oltrecolli, Marco
    Pirola, Marta
    D'Agostino, Elisa
    Pugliese, Giuseppe
    Cerri, Sara
    Vitale, Maria Giuseppa
    Madeo, Bruno
    Dominici, Massimo
    Sabbatini, Roberto
    CANCERS, 2023, 15 (05)
  • [36] Characterization of Bone Metastases from Rapid Autopsies of Prostate Cancer Patients
    Mehra, Rohit
    Kumar-Sinha, Chandan
    Shankar, Sunita
    Lonigro, Robert J.
    Jing, Xiaojun
    Philips, Neena E.
    Siddiqui, Javed
    Han, Bo
    Cao, Xuhong
    Smith, David C.
    Shah, Rajal B.
    Chinnaiyan, Arul M.
    Pienta, Kenneth J.
    CLINICAL CANCER RESEARCH, 2011, 17 (12) : 3924 - 3932
  • [37] New agents for treatment and prevention of bone metastases from prostate cancer
    Smith, M. R.
    CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 : 18 - 18
  • [38] Pathophysiology of bone metastases from prostate cancer and the role of bisphosphonates in treatment
    Eaton, CL
    Coleman, RE
    CANCER TREATMENT REVIEWS, 2003, 29 (03) : 189 - 198
  • [39] Unexplained Bone Pain Is an Independent Risk Factor for Bone Metastases in Newly Diagnosed Prostate Cancer: A Prospective Study
    Zacho, Helle D.
    Morch, Carsten D.
    Barsi, Tamas
    Mortensen, Jesper C.
    Bertelsen, Henrik
    Petersen, Lars J.
    UROLOGY, 2017, 99 : 148 - 154
  • [40] Bone Pain, Skeletal-Related Events and Opioid Analgesic Use in Prostate Cancer Patients with Bone Metastases
    Valderrama, Adriana
    Eapen, Sara
    Hennessey, Kelly A.
    Jones, Casey
    Wen, Lonnie
    Germino, Joseph
    Duh, Mei S.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 473 - 473